Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / HLA Protein Technologies
Entity

HLA Protein Technologies

Tracked across 1 events · 6 articles · First seen Aug 11, 2026 · Last active Aug 11, 2026

Sentiment
70
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 70
Business
HLA Protein Technologies Secures NCI TCR License
HLA Protein Technologies, Inc., a private company based in Oklahoma City, announced on August 11, 2026, that it has secured an internal use license from the United States — National Cancer Institute (NCI), a component…
Impact: Secured a key license from the NCI, enabling expansion of its TCR and HLA product portfolio and manufacturing. This strengthens its position in the immunotherapy research tools market and supports its commercialization strategy.
Aug 11, 2026 · 6 articles
Key Actions (1)
90 HLA Protein Technologies secured license United States — National Cancer InstituteHLA Protein Technologies...
ERGEN INTELLIGENCE
Track HLA Protein Technologies live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.